We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICE icon
126
Intercontinental Exchange
ICE
$86B
$29.9M 0.17%
186,266
+7,139
+4% +$1.1M
IDYA icon
127
IDEAYA Biosciences
IDYA
$3.47B
$29.8M 0.17%
940,440
+311,421
+50% +$11.8M
DDOG icon
128
Datadog
DDOG
$89.2B
$29.7M 0.17%
258,030
+94
+0% +$11K
CL icon
129
Colgate-Palmolive
CL
$74.9B
$28.8M 0.17%
277,498
+31,945
+13% +$3.26M
MCD icon
130
McDonald's
MCD
$194B
$28.5M 0.16%
93,669
-4,321
-4% -$1.19M
IBM icon
131
IBM
IBM
$215B
$28.4M 0.16%
128,329
-9,336
-7% -$1.83M
LULU icon
132
lululemon athletica
LULU
$13.7B
$28.3M 0.16%
104,459
-13,402
-11% -$3.56M
SBUX icon
133
Starbucks
SBUX
$117B
$27.9M 0.16%
286,565
-34,578
-11% -$2.97M
ARGX icon
134
argenx
ARGX
$55B
$27.9M 0.16%
51,418
– –
MEDP icon
135
Medpace
MEDP
$16.3B
$27.8M 0.16%
83,281
+8,720
+12% +$3.31M
KKR icon
136
KKR & Co
KKR
$91.9B
$27.5M 0.16%
210,253
+42,286
+25% +$5M
DNLI icon
137
Denali Therapeutics
DNLI
$3.75B
$27.4M 0.16%
942,158
+215,659
+30% +$5.35M
VLTO icon
138
Veralto
VLTO
$23.8B
$27.3M 0.16%
244,323
-3,599
-1% -$380K
EBAY icon
139
eBay
EBAY
$51.7B
$27.2M 0.16%
417,983
+69,655
+20% +$4.01M
ZS icon
140
Zscaler
ZS
$24.7B
$27.1M 0.16%
158,777
+135,075
+570% +$24.7M
SWTX
141
DELISTED
SpringWorks Therapeutics
SWTX
$27.1M 0.16%
845,170
+323,066
+62% +$12.1M
GWW icon
142
W.W. Grainger
GWW
$65.6B
$27M 0.16%
26,018
+20,269
+353% +$19.6M
BRKR icon
143
Bruker
BRKR
$9.45B
$26.3M 0.15%
380,784
+59,579
+19% +$3.85M
EL icon
144
Estee Lauder
EL
$30.7B
$26.1M 0.15%
261,947
+104,121
+66% +$9.87M
RVMD icon
145
Revolution Medicines
RVMD
$38.9B
$25.6M 0.15%
563,782
+9,448
+2% +$411K
TD icon
146
Toronto Dominion Bank
TD
$199B
$25.2M 0.14%
397,343
-71,397
-15% -$4.22M
SPG icon
147
Simon Property Group
SPG
$76.9B
$25.1M 0.14%
148,615
+77,942
+110% +$12.3M
ZBRA icon
148
Zebra Technologies
ZBRA
$13.1B
$25.1M 0.14%
67,745
-3,633
-5% -$1.22M
STN icon
149
Stantec
STN
$8.19B
$24.6M 0.14%
305,452
+101,047
+49% +$8.36M
GE icon
150
GE Aerospace
GE
$377B
$24.1M 0.14%
127,783
+5,452
+4% +$924K
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.